Published in Hum Mutat on July 01, 2008
Glycogen storage disease type I and G6Pase-β deficiency: etiology and therapy. Nat Rev Endocrinol (2010) 1.32
Glucose-6-phosphatase catalytic subunit gene family. J Biol Chem (2009) 1.30
Natural history of hepatocellular adenoma formation in glycogen storage disease type I. J Pediatr (2011) 1.20
Glucose-6-phosphatase deficiency. Orphanet J Rare Dis (2011) 1.12
Glycogen metabolism in humans. BBA Clin (2016) 0.95
Insights into the pathogenesis and treatment of cancer from inborn errors of metabolism. Am J Hum Genet (2011) 0.91
A clinical and molecular review of ubiquitous glucose-6-phosphatase deficiency caused by G6PC3 mutations. Orphanet J Rare Dis (2013) 0.87
Integrative bioinformatics links HNF1B with clear cell carcinoma and tumor-associated thrombosis. PLoS One (2013) 0.86
Control of gene expression by the retinoic acid-related orphan receptor alpha in HepG2 human hepatoma cells. PLoS One (2011) 0.85
Glycogen Storage Disease type 1a - a secondary cause for hyperlipidemia: report of five cases. J Diabetes Metab Disord (2013) 0.85
A retrospective review of the roles of multifunctional glucose-6-phosphatase in blood glucose homeostasis: Genesis of the tuning/retuning hypothesis. Life Sci (2010) 0.82
In vivo gut transcriptome responses to Lactobacillus rhamnosus GG and Lactobacillus acidophilus in neonatal gnotobiotic piglets. Gut Microbes (2014) 0.79
Type I glycogen storage diseases: disorders of the glucose-6-phosphatase/glucose-6-phosphate transporter complexes. J Inherit Metab Dis (2014) 0.77
Effects of adult onset mild calorie restriction on weight of reproductive organs, plasma parameters and gene expression in male mice. Anim Reprod (2012) 0.76
Three novel mutations of the G6PC gene identified in Chinese patients with glycogen storage disease type Ia. Eur J Pediatr (2014) 0.75
Liver glucose metabolism in humans. Biosci Rep (2016) 0.75
Liver tumors in children with metabolic disorders. Transl Pediatr (2015) 0.75
Tophaceous gout in a female premenopausal patient with an unexpected diagnosis of glycogen storage disease type Ia: a case report and literature review. Clin Rheumatol (2016) 0.75
Mutation nomenclature extensions and suggestions to describe complex mutations: a discussion. Hum Mutat (2000) 13.25
Nomenclature for the description of human sequence variations. Hum Genet (2001) 7.90
Identification of a consensus motif for retention of transmembrane proteins in the endoplasmic reticulum. EMBO J (1990) 7.03
Glycogen storage disease type I: diagnosis, management, clinical course and outcome. Results of the European Study on Glycogen Storage Disease Type I (ESGSD I). Eur J Pediatr (2002) 2.21
Mutations in the glucose-6-phosphatase gene that cause glycogen storage disease type 1a. Science (1993) 2.07
Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex. Curr Mol Med (2002) 1.96
Cornstarch therapy in type I glycogen-storage disease. N Engl J Med (1984) 1.88
Glucose-6-phosphatase dependent substrate transport in the glycogen storage disease type-1a mouse. Nat Genet (1996) 1.88
Sequence of a putative glucose 6-phosphate translocase, mutated in glycogen storage disease type Ib. FEBS Lett (1997) 1.86
Identification of a novel phosphatase sequence motif. Protein Sci (1997) 1.78
Mutation frequencies for glycogen storage disease Ia in the Ashkenazi Jewish population. Am J Med Genet A (2004) 1.59
Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature. J Pediatr Gastroenterol Nutr (1997) 1.50
Renal disease in type I glycogen storage disease. N Engl J Med (1988) 1.45
The putative glucose 6-phosphate translocase gene is mutated in essentially all cases of glycogen storage disease type I non-a. Eur J Hum Genet (1999) 1.42
Continuous nocturnal intragastric feeding for management of type 1 glycogen-storage disease. N Engl J Med (1976) 1.41
Neutropenia, neutrophil dysfunction, and inflammatory bowel disease in glycogen storage disease type Ib: results of the European Study on Glycogen Storage Disease type I. J Pediatr (2000) 1.41
Effect of continuous glucose therapy with uncooked cornstarch on the long-term clinical course of type 1a glycogen storage disease. Eur J Pediatr (2002) 1.35
Early, sustained efficacy of adeno-associated virus vector-mediated gene therapy in glycogen storage disease type Ia. Gene Ther (2006) 1.35
A glucose-6-phosphate hydrolase, widely expressed outside the liver, can explain age-dependent resolution of hypoglycemia in glycogen storage disease type Ia. J Biol Chem (2003) 1.33
Transmembrane topology of glucose-6-phosphatase. J Biol Chem (1998) 1.33
Inactivation of the glucose 6-phosphate transporter causes glycogen storage disease type 1b. J Biol Chem (1999) 1.31
A gene on chromosome 11q23 coding for a putative glucose- 6-phosphate translocase is mutated in glycogen-storage disease types Ib and Ic. Am J Hum Genet (1998) 1.28
From phosphatases to vanadium peroxidases: a similar architecture of the active site. Proc Natl Acad Sci U S A (1997) 1.24
Evidence for the involvement of a glucose-6-phosphate carrier in microsomal glucose-6-phosphatase activity. Eur J Biochem (1978) 1.24
Glycogen storage disease type I: pathophysiology of liver adenomas. Eur J Pediatr (2002) 1.23
Structure-function analysis of the glucose-6-phosphate transporter deficient in glycogen storage disease type Ib. Hum Mol Genet (2002) 1.21
Identification of mutations in the gene for glucose-6-phosphatase, the enzyme deficient in glycogen storage disease type 1a. J Clin Invest (1994) 1.20
Mutations in the glucose-6-phosphatase gene are associated with glycogen storage disease types 1a and 1aSP but not 1b and 1c. J Clin Invest (1995) 1.20
Identification and characterization of a human cDNA and gene encoding a ubiquitously expressed glucose-6-phosphatase catalytic subunit-related protein. J Mol Endocrinol (2002) 1.14
Ontogeny of the murine glucose-6-phosphatase system. Arch Biochem Biophys (1998) 1.13
Genotype/phenotype correlation in glycogen storage disease type 1b: a multicentre study and review of the literature. Eur J Pediatr (2005) 1.13
Histidine 167 is the phosphate acceptor in glucose-6-phosphatase-beta forming a phosphohistidine enzyme intermediate during catalysis. J Biol Chem (2004) 1.11
Association of glycogen storage disease 1b and Crohn disease: results of a North American survey. Eur J Pediatr (2002) 1.11
The catalytic center of glucose-6-phosphatase. HIS176 is the nucleophile forming the phosphohistidine-enzyme intermediate during catalysis. J Biol Chem (2002) 1.10
Glycogen storage disease I and hepatocellular tumours. Eur J Pediatr (1993) 1.10
Long-term correction of murine glycogen storage disease type Ia by recombinant adeno-associated virus-1-mediated gene transfer. Gene Ther (2006) 1.07
Structure-function analysis of human glucose-6-phosphatase, the enzyme deficient in glycogen storage disease type 1a. J Biol Chem (1995) 1.07
Identification and characterisation of a new human glucose-6-phosphatase isoform. FEBS Lett (2003) 1.06
Delivery of glucose-6-phosphatase in a canine model for glycogen storage disease, type Ia, with adeno-associated virus (AAV) vectors. Gene Ther (2002) 1.04
Decreased urinary citrate excretion in type 1a glycogen storage disease. J Pediatr (2001) 1.03
Canine model and genomic structural organization of glycogen storage disease type Ia (GSD Ia). Vet Pathol (2001) 1.02
The gene for glycogen-storage disease type 1b maps to chromosome 11q23. Am J Hum Genet (1998) 1.01
Glucose-6-phosphatase mutation G188R confers an atypical glycogen storage disease type 1b phenotype. Pediatr Res (2000) 1.01
Mutations in the glucose-6-phosphate transporter (G6PT) gene in patients with glycogen storage diseases type 1b and 1c. FEBS Lett (1999) 0.98
The molecular basis of glycogen storage disease type 1a: structure and function analysis of mutations in glucose-6-phosphatase. J Biol Chem (2001) 0.98
Sustained hepatic and renal glucose-6-phosphatase expression corrects glycogen storage disease type Ia in mice. Hum Mol Genet (2002) 0.97
Protein-bound phosphoryl histidine: a probable intermediate in the microsomal glucose-6-phosphatase-inorganic pyrophosphatase reaction. Biochim Biophys Acta (1972) 0.97
Molecular Genetics of Type 1 Glycogen Storage Diseases. Trends Endocrinol Metab (1999) 0.96
Glycogen storage disease type Ia: recent experience with mutation analysis, a summary of mutations reported in the literature and a newly developed diagnostic flow chart. Eur J Pediatr (2000) 0.95
Angiotensin mediates renal fibrosis in the nephropathy of glycogen storage disease type Ia. Kidney Int (2007) 0.94
Isolation and nucleotide sequence of canine glucose-6-phosphatase mRNA: identification of mutation in puppies with glycogen storage disease type Ia. Biochem Mol Med (1997) 0.94
Genetic basis of glycogen storage disease type 1a: prevalent mutations at the glucose-6-phosphatase locus. Am J Hum Genet (1995) 0.94
Structural requirements for the stability and microsomal transport activity of the human glucose 6-phosphate transporter. J Biol Chem (2000) 0.89
Hyperfiltration and renal disease in glycogen storage disease, type I. Kidney Int (1989) 0.88
Glycogen storage disease type Ia in Argentina: two novel glucose-6-phosphatase mutations affecting protein stability. Mol Genet Metab (2004) 0.88
A new model for the membrane topology of glucose-6-phosphatase: the enzyme involved in von Gierke disease. FEBS Lett (1997) 0.86
Glycogen storage disease type Ib without neutropenia. J Pediatr (2000) 0.86
Characterization of the mutations in the glucose-6-phosphatase gene in Israeli patients with glycogen storage disease type 1a: R83C in six Jews and a novel V166G mutation in a Muslim Arab. J Inherit Metab Dis (1995) 0.86
Glycogen storage disease type I: diagnosis and phenotype/genotype correlation. Eur J Pediatr (2002) 0.84
A new mutation of the glucose-6-phosphatase gene in a 4-year-old girl with oligosymptomatic glycogen storage disease type 1a. J Pediatr (1998) 0.83
Mutation analysis in glycogen storage disease type 1 non-a. Hum Genet (2000) 0.83
Glycogen storage disease type Ib without neutropenia generated by a novel splice-site mutation in the glucose-6-phosphate translocase gene. Mol Genet Metab (2006) 0.82
A patient with common glycogen storage disease type Ib mutations without neutropenia or neutrophil dysfunction. J Inherit Metab Dis (2006) 0.81
Glycogen storage disease type 1a in Israel: biochemical, clinical, and mutational studies. Am J Med Genet (1997) 0.80
Identification of a novel mutation (867delA) in the glucose-6-phosphatase gene in two siblings with glycogen storage disease type Ia with different phenotypes. Hum Mutat (2000) 0.79
Exon redefinition by a point mutation within exon 5 of the glucose-6-phosphatase gene is the major cause of glycogen storage disease type 1a in Japan. Am J Hum Genet (1995) 0.79
Glucose-6-phosphatase gene mutations in 20 adult Japanese patients with glycogen storage disease type 1a with reference to hepatic tumors. J Gastroenterol Hepatol (2001) 0.79
Mutations in the glucose-6-phosphatase gene of 53 Italian patients with glycogen storage disease type Ia. J Inherit Metab Dis (1999) 0.79
Heterogeneous mutations in the glucose-6-phosphatase gene in Japanese patients with glycogen storage disease type Ia. Am J Med Genet (2000) 0.79
Type I glycogen storage disease: favourable outcome on a strict management regimen avoiding increased lactate production during childhood and adolescence. Eur J Pediatr (2002) 0.79
Mutation spectrum of the glucose-6-phosphatase gene and its implication in molecular diagnosis of Korean patients with glycogen storage disease type Ia. Clin Genet (2004) 0.78
Glycogen storage disease type Ia: molecular study in Brazilian patients. J Hum Genet (2001) 0.78
Mutation analysis in 24 French patients with glycogen storage disease type 1a. J Med Genet (1996) 0.78
Asparagine-linked oligosaccharides are localized to a luminal hydrophilic loop in human glucose-6-phosphatase. J Biol Chem (1998) 0.78
Two new mutations in the glucose-6-phosphatase gene cause glycogen storage disease in Hungarian patients. Eur J Hum Genet (1998) 0.78
Glycogen storage disease type Ia: molecular diagnosis of 51 Japanese patients and characterization of splicing mutations by analysis of ectopically transcribed mRNA from lymphoblastoid cells. Am J Med Genet (2000) 0.77
Molecular aspects of glycogen storage disease type Ia in Turkish patients: a novel mutation in the glucose-6-phosphatase gene. J Inherit Metab Dis (1998) 0.77
Glucose-6-phosphatase gene (727G-->T) splicing mutation is prevalent in Hong Kong Chinese patients with glycogen storage disease type 1a. Clin Genet (1998) 0.76
Identification of a novel missense mutation (T16A) in the glucose-6-phosphatase gene in a Taiwan Chinese patient with glycogen storage disease Ia (Von Gierke disease). Hum Mutat (2000) 0.76
Identification of mutations in the glucose-6-phosphatase gene in Czech and Slovak patients with glycogen storage disease type ia, including novel mutations K76N, V166A and 540del5. Hum Mutat (2000) 0.76
Glycogen storage disease type 1a in three siblings with the G270V mutation. J Inherit Metab Dis (1999) 0.76
Glucose-6-phosphatase gene mutations in Taiwan Chinese patients with glycogen storage disease type Ia. J Hum Genet (2000) 0.76
Genetic heterogeneity of glycogen storage disease type Ia in France: a study of 48 patients. Hum Mutat (2000) 0.76
A novel missense mutation (H119L) identified in a Taiwan Chinese family with glycogen storage disease Ia (Von Gierke disease). Hum Mutat (2000) 0.76
Identification of a novel nonsense mutation (Q24X) in the glucose-6-phosphatase gene of a Portuguese patient with GSD Ia (von Gierke disease). Hum Mutat (2000) 0.76
A novel mutation in the glucose-6-phosphatase gene in Korean twins with glycogen storage disease type Ia. J Inherit Metab Dis (2000) 0.76
Enzymatic characterization of four new mutations in the glucose-6 phosphatase (G6PC) gene which cause glycogen storage disease type 1a. Ann Hum Genet (1999) 0.76
Molecular genetics of glycogen-storage disease type 1a in Chinese patients of Taiwan. Mol Genet Metab (2001) 0.76
Hypercalcaemia in glycogen storage disease type Ia: a case with R83H and 341delG mutations. J Inherit Metab Dis (1999) 0.76
A case of glycogen storage disease type Ia with multiple hepatic adenomas and G727T mutation in the glucose-6-phosphatase gene, and a comparison with other mutations previously reported. Am J Gastroenterol (1998) 0.76
A common 2 bp deletion mutation in the glucose-6-phosphatase gene in Indian patients with glycogen storage disease type Ia. J Inherit Metab Dis (2001) 0.76
Glucose-6-phosphatase gene mutations in Turkish patients with glycogen storage disease type Ia. J Inherit Metab Dis (2001) 0.76
Molecular genetic analysis of 40 patients with glycogen storage disease type Ia: 100% mutation detection rate and 5 novel mutations. Hum Mutat (2000) 0.76
Identification of a point mutation (G727T) in the glucose-6-phosphatase gene in Japanese patients with glycogen storage disease type 1a, and carrier screening in healthy volunteers. Clin Genet (1997) 0.76
Genetic analysis of the glucose-6-phosphatase mutation of type 1a glycogen storage disease in a Chinese family. Clin Genet (1996) 0.76
The inheritance of a novel mutation in glycogen storage disease type 1a. Biochem Soc Trans (1996) 0.76
Verification of diagnosis in a 17-year-old boy with clinical glycogen storage disease type Ia by mutation screening. J Inherit Metab Dis (1996) 0.76
Molecular genetic analysis of glycogen storage disease type Ia in 26 Chinese patients. J Inherit Metab Dis (2003) 0.76
Glucose-6-phosphatase gene G327A mutation is common in Chinese patients with glycogen storage disease type Ia. Hum Mol Genet (1995) 0.76
Mutation spectrum of type I glycogen storage disease in Hungary. J Inherit Metab Dis (2005) 0.76
Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex. Curr Mol Med (2002) 1.96
Prevention of hepatocellular adenoma and correction of metabolic abnormalities in murine glycogen storage disease type Ia by gene therapy. Hepatology (2012) 1.59
Multianalyte profiling of serum antigens and autoimmune and infectious disease molecules to identify biomarkers dysregulated in epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev (2008) 1.54
Molecular mechanisms of neutrophil dysfunction in glycogen storage disease type Ib. Blood (2014) 1.52
Impaired neutrophil activity and increased susceptibility to bacterial infection in mice lacking glucose-6-phosphatase-beta. J Clin Invest (2007) 1.41
A glucose-6-phosphate hydrolase, widely expressed outside the liver, can explain age-dependent resolution of hypoglycemia in glycogen storage disease type Ia. J Biol Chem (2003) 1.33
Glycogen storage disease type I and G6Pase-β deficiency: etiology and therapy. Nat Rev Endocrinol (2010) 1.32
Complete normalization of hepatic G6PC deficiency in murine glycogen storage disease type Ia using gene therapy. Mol Ther (2010) 1.21
Impaired glucose homeostasis, neutrophil trafficking and function in mice lacking the glucose-6-phosphate transporter. Hum Mol Genet (2003) 1.15
Neutrophil stress and apoptosis underlie myeloid dysfunction in glycogen storage disease type Ib. Blood (2008) 1.11
Gene therapy for type I glycogen storage diseases. Curr Gene Ther (2007) 1.07
Brain contains a functional glucose-6-phosphatase complex capable of endogenous glucose production. J Biol Chem (2005) 1.06
The glucose-6-phosphate transporter is a phosphate-linked antiporter deficient in glycogen storage disease type Ib and Ic. FASEB J (2008) 1.03
Development and preliminary evaluation of a multivariate index assay for ovarian cancer. PLoS One (2009) 1.02
SLC37A1 and SLC37A2 are phosphate-linked, glucose-6-phosphate antiporters. PLoS One (2011) 1.01
Neutropenia in type Ib glycogen storage disease. Curr Opin Hematol (2010) 0.98
Sustained hepatic and renal glucose-6-phosphatase expression corrects glycogen storage disease type Ia in mice. Hum Mol Genet (2002) 0.97
Bone marrow-derived cells require a functional glucose 6-phosphate transporter for normal myeloid functions. J Biol Chem (2006) 0.97
Necrotic foci, elevated chemokines and infiltrating neutrophils in the liver of glycogen storage disease type Ia. J Hepatol (2007) 0.92
A potential new role for muscle in blood glucose homeostasis. J Biol Chem (2004) 0.92
Comprehensive serum profiling for the discovery of epithelial ovarian cancer biomarkers. PLoS One (2011) 0.91
Glucose-6-phosphatase-β, implicated in a congenital neutropenia syndrome, is essential for macrophage energy homeostasis and functionality. Blood (2012) 0.87
Recombinant AAV-directed gene therapy for type I glycogen storage diseases. Expert Opin Biol Ther (2011) 0.85
G-CSF improves murine G6PC3-deficient neutrophil function by modulating apoptosis and energy homeostasis. Blood (2011) 0.83
The islet-specific glucose-6-phosphatase-related protein, implicated in diabetes, is a glycoprotein embedded in the endoplasmic reticulum membrane. FEBS Lett (2004) 0.82
Normoglycemia alone is insufficient to prevent long-term complications of hepatocellular adenoma in glycogen storage disease type Ib mice. J Hepatol (2009) 0.82
The upstream enhancer elements of the G6PC promoter are critical for optimal G6PC expression in murine glycogen storage disease type Ia. Mol Genet Metab (2013) 0.80
The signature motif in human glucose-6-phosphate transporter is essential for microsomal transport of glucose-6-phosphate. Hum Genet (2003) 0.79
Oxidative stress mediates nephropathy in type Ia glycogen storage disease. Lab Invest (2010) 0.77
Type I glycogen storage diseases: disorders of the glucose-6-phosphatase/glucose-6-phosphate transporter complexes. J Inherit Metab Dis (2014) 0.77
The SLC37 family of phosphate-linked sugar phosphate antiporters. Mol Aspects Med (2013) 0.76
A method for assessing and maintaining the reproducibility of mass spectrometric analyses of complex samples. Rapid Commun Mass Spectrom (2009) 0.75
A method for monitoring and controlling reproducibility of intensity data in complex electrospray mass spectra: a thermometer ion-based strategy. J Am Soc Mass Spectrom (2008) 0.75